Changes in Profiles of Kawasaki Disease Noted over Time in Suzhou, China
暂无分享,去创建一个
Bo Wang | Guang-Hui Qian | Yunjia Tang | Xuan Li | H. Lv | Ling Sun | Wen-hua Yan | Ye Wang
[1] Guo-ying Huang,et al. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017 , 2019, Journal of epidemiology.
[2] K. Kotani,et al. Epidemiological observations of Kawasaki disease in Japan, 2013–2014 , 2018, Pediatrics international : official journal of the Japan Pediatric Society.
[3] Hiroyuki Suzuki,et al. Patient Age and the Seasonal Pattern of Onset of Kawasaki's Disease. , 2018, The New England journal of medicine.
[4] T. Fukaya,et al. Kawasaki disease: Epidemiological differences between past and recent periods, and implications of distribution dynamism , 2018, Pediatrics international : official journal of the Japan Pediatric Society.
[5] L. Schonberger,et al. Cardiac Complications, Earlier Treatment, and Initial Disease Severity in Kawasaki Disease , 2017, The Journal of pediatrics.
[6] H. Kil,et al. Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea , 2017, Pediatric Rheumatology.
[7] Sohee Park,et al. Epidemiology and Clinical Features of Kawasaki Disease in South Korea, 2012–2014 , 2017, The Pediatric infectious disease journal.
[8] M. Krucoff,et al. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. , 2016, JAMA pediatrics.
[9] Yunjia Tang,et al. Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience. , 2016, Journal of tropical pediatrics.
[10] Fang Liu,et al. Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012 , 2015, The Pediatric infectious disease journal.
[11] Ping Huang,et al. Influenza infection and Kawasaki disease. , 2015, Revista da Sociedade Brasileira de Medicina Tropical.
[12] K. Kotani,et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. , 2015, Journal of epidemiology.
[13] K. Kotani,et al. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. , 2015, Journal of epidemiology.
[14] T. Kuijpers,et al. Five Years of Kawasaki Disease in the Netherlands: A National Surveillance Study , 2014, The Pediatric infectious disease journal.
[15] K. Maslin,et al. The Epidemiology and Clinical Features of Kawasaki Disease in Australia , 2014, Pediatrics.
[16] Jung-Woo Rhim,et al. Changes in Kawasaki Disease During 2 Decades at a Single Institution in Daejeon, Korea , 2014, The Pediatric infectious disease journal.
[17] Chin‐Yun Lee,et al. Estimation of the incidence of Kawasaki disease in Taiwan. A comparison of two data sources: nationwide hospital survey and national health insurance claims. , 2014, Pediatrics and neonatology.
[18] Xiaodong Zhao,et al. Clinical Characteristics of Kawasaki Syndrome and the Risk Factors for Coronary Artery Lesions in China , 2013, The Pediatric infectious disease journal.
[19] R. Holman,et al. Kawasaki Syndrome and Factors Associated With Coronary Artery Abnormalities in California , 2012, The Pediatric infectious disease journal.
[20] Jinghui Sun,et al. Epidemiologic Survey of Kawasaki Disease in Jilin from 1999 Through 2008 , 2011, Pediatric Cardiology.
[21] Junbao Du,et al. VALGANCICLOVIR FOR CONGENITAL CMV INFECTION: A PILOT STUDY ON PLASMA CONCENTRATION IN NEWBORNS AND INFANTS , 2007, The Pediatric infectious disease journal.
[22] J. Furui,et al. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. , 2006, Acta paediatrica.
[23] J. Furui,et al. Risk factors associated with the need for additional intravenous gamma‐globulin therapy for Kawasaki disease , 2006, Acta paediatrica.